COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study
暂无分享,去创建一个
J. Wachowiak | W. Młynarski | N. Irga-Jaworska | T. Szczepański | B. Kazanowska | M. Matysiak | J. Styczyński | W. Balwierz | M. Ussowicz | B. Dembowska-Baginska | E. Bien | T. Ociepa | Agnieszka Kruk | A. Szmydki-Baran | R. Chaber | O. Zając‐Spychała | M. Krawczuk-Rybak | A. Zaucha-Prażmo | A. Raciborska | Agnieszka A. Książek | J. Peregud-Pogorzelski | A. Mizia-Malarz | J. Węcławek-Tompol | Z. Zakrzewska | O. Gryniewicz-Kwiatkowska | F. Pierlejewski | W. Bal | M. Sawicka-Żukowska | Agnieszka Matkowska-Kocjan | E. Bień | J. Weclawek-Tompol
[1] A. Prata‐Barbosa,et al. Screening of COVID-19 in outpatient children with cancer or solid organ transplantation: preliminary report , 2021, European Journal of Pediatrics.
[2] D. Sarfati,et al. Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic , 2021, Ecancermedicalscience.
[3] M. Devidas,et al. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study , 2021, The Lancet Child & Adolescent Health.
[4] A. Matos,et al. COVID-19 cohort on children with cancer: delay in treatment and increased frequency of deaths , 2021 .
[5] M. Dimopoulos,et al. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications , 2021, Journal of biomedical science.
[6] J. Wachowiak,et al. Epidemiology and prevention strategies of SARS-CoV-2 infection in pediatric hematology and oncology centers in Poland , 2020, Acta Haematologica Polonica.
[7] M. Cevik,et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis , 2020, The Lancet Microbe.
[8] V. Thiel,et al. Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.
[9] L. Diller,et al. Timely pediatric cancer diagnoses: An unexpected casualty of the COVID‐19 surge , 2020, Pediatric blood & cancer.
[10] M. Ussowicz,et al. SARS‐CoV‐2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation—A case report , 2020, Pediatric transplantation.
[11] A. Ferrari,et al. A collateral effect of the COVID‐19 pandemic: Delayed diagnosis in pediatric solid tumors , 2020, Pediatric blood & cancer.
[12] C. Murray,et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.
[13] M. M. van der Eerden,et al. Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants , 2020, medRxiv.
[14] P. Kearns,et al. The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global , 2020, Pediatric blood & cancer.
[15] Akihide Ryo,et al. Interpreting Diagnostic Tests for SARS-CoV-2. , 2020, JAMA.
[16] E. Petersen,et al. SARS-CoV-2 shedding and infectivity , 2020, The Lancet.
[17] S. Rives,et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment , 2020, European journal of cancer.
[18] S. Rives,et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment , 2020, European Journal of Cancer.
[19] Qiurong Ruan,et al. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[20] C. Rodríguez-Galindo,et al. Early advice on managing children with cancer during the COVID‐19 pandemic and a call for sharing experiences , 2020, Pediatric blood & cancer.
[21] E. Bosdure,et al. COVID-19 virus and children: What do we know? , 2020, Archives de Pédiatrie.
[22] Zhiyong Ma,et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia , 2020, The Journal of infectious diseases.
[23] Beijing China. Prevention,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China , 2020 .
[24] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[25] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[26] Bo Diao,et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) , 2020, Frontiers in Immunology.
[27] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[28] Publisher's Note , 2018, Anaesthesia.
[29] B. Morland,et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study , 2013, The Lancet. Oncology.
[30] Xin Shi,et al. Chemotherapy dose-intensity and survival for childhood medulloblastoma. , 2012, Anticancer research.